Japan’s Ministry Eliminates State Level Review For Embryonic Stem Cell Research
This article was originally published in PharmAsia News
To accelerate embryonic stem cell basic research in Japan, the Ministry of Education, Science and Technology decided March 17 to eliminate the state level review process for such research projects. Current guidelines require researchers in Japan obtain approvals from both individual institutes and the Ministry, and it usually takes two months to obtain a state approval. (Click here for more - Japanese language
You may also be interested in...
Biocon’s itolizumab gets clearance in India for restricted emergency use in COVID-19 patients, amid some concerns around small study numbers. But company says data are compelling and cites compassionate use substantiation, while partner Equillium expects to pursue a global study under US IND.
Clinical Trials: Industry Navigating Alternative Ways Of Delivering Investigational Drugs During Pandemic
New approaches include delivering study drug from a clinical site directly to a patient’s house through a courier service, as well as use of drones and automated dispensing units; future trials could see a mix of delivery approaches.
Benefits of the BCMA-directed antibody-drug conjugate outweigh its ocular risks in heavily pretreated multiple myeloma patients, Oncologic Drugs Advisory Committee says at the conclusion of a virtual meeting beset by technical problems.